Envestnet Portfolio Solutions, Inc.

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1998033 BERWYN, PA

Position in REGN

as of Jun 30, 2026 · filed Jul 20, 2026 Compact

Position Value

$592,363

-$136,236 QoQ

Shares Held

950

+0.7% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#764

of 1,322 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Envestnet Portfolio Solutions, Inc. holds $15,944,229 across 18 Biotechnology names. REGN ranks #11 (3.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	8,064	$4,005,630
2	JAZZ	Jazz Pharmaceuticals plc	8,030	$1,934,989
3	ALNY	Alnylam Pharmaceuticals, Inc.	4,635	$1,395,274
4	TGTX	Tg Therapeutics, Inc.	21,192	$1,164,288
5	PTCT	Ptc Therapeutics, Inc.	13,730	$1,119,956
6	CORT	Corcept Therapeutics Inc	10,617	$923,148
7	HALO	Halozyme Therapeutics, Inc.	11,409	$892,982
8			21,996	$691,334

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$592,363	950	+0.7%	Shares	Sole	2026-07-20
2026-03-31	$728,599	943	-57.0%	Shares	Sole	2026-04-29
2025-12-31	$1,694,254	2,195	+0.5%	Shares	Sole	2026-02-06
2025-09-30	$1,227,435	2,183	+0.6%	Shares	Sole	2025-10-30
2025-06-30	$1,138,725	2,169	+22.5%	Shares	Sole	2025-07-25
2025-03-31	$1,123,221	1,771	-34.0%	Shares	Sole	2025-04-21
2024-12-31	$1,911,893	2,684	+36.2%	Shares	Sole	2025-02-10
2024-09-30	$2,071,994	1,971	+16.5%	Shares	Sole	2024-10-31
2024-06-30	$1,778,342	1,692	+6.5%	Shares	Sole	2024-07-16
2024-03-31	$1,528,434	1,588	+33.7%	Shares	Sole	2024-05-06
2023-12-31	$1,043,408	1,188	+45.2%	Shares	Sole	2024-02-07
2023-09-30	$673,181	818	—	Shares	Sole	2023-11-13
No filing history on record for this holder in this stock.